Evidence map›Paper›PMID 29651324›Full record

ArticleDisease markers2018

Cerebellum Susceptibility to Neonatal Asphyxia: Possible Protective Effects of N-Acetylcysteine Amide.

T Benterud, S Manueldas, S Rivera, E Henckel, E M Løberg, S Norgren, L O Baumbusch, R Solberg, O D Saugstad

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

T BenterudDepartment of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.ORCID 0000-0003-2094-6170
S ManueldasDepartment of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
S RiveraAix Marseille Université, CNRS, NICN, Marseille, France.
E HenckelDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
E M LøbergUniversity of Oslo, Oslo, Norway.
S NorgrenDepartment of Women's and Children's Health, Division of Paediatric Endocrinology, Karolinska Institutet, Stockholm, Sweden.
L O BaumbuschDepartment of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
R SolbergDepartment of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.ORCID 0000-0003-4042-6076
O D SaugstadDepartment of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Oslo University Hospital · NOCentre National de la Recherche Scientifique · FRKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter perinatal asphyxia, the cerebellum presents more damage than previously suggested.

objectivesTo explore if the antioxidant N-acetylcysteine amide (NACA) could reduce cerebellar injury after hypoxia-reoxygenation in a neonatal pig model.

methodsTwenty-four newborn pigs in two intervention groups were exposed to 8% oxygen and hypercapnia, until base excess fell to -20 mmol/l or the mean arterial blood pressure declined to <20 mmHg. After hypoxia, they received either NACA (NACA group,

resultsThe intranuclear proteolytic activity in Purkinje cells of asphyxiated vehicle-treated pigs was significantly higher than that in sham controls (

conclusionWe found a trend to lower proteolytic activity in the core of Purkinje cells and significantly reduced mutation rate of mtDNA in the NACA group, which may indicate a positive effect of NACA after neonatal hypoxia. Measuring the proteolytic activity in the nucleus of Purkinje cells could be used to assess the effect of different neuroprotective substances after perinatal asphyxia.

Indexed as

AcetylcysteineAnimalsAsphyxia NeonatorumDisease Models, AnimalDNA, MitochondrialHumansInfant, NewbornMutation RateNeuroprotective AgentsProteolysisPurkinje CellsSwineAcetylcysteineDNA, MitochondrialN-AcetylcysteinamideNeuroprotective Agents

Identifiers

PMID29651324
PMCPMC5831588
OpenAlexW2789708444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.